Optomed Oyj

Transaction in Own Shares • Aug 7, 2023

Disclosure 435850

Optomed Oyj - Changes in company's own shares

Change in Optomed's holding of treasury shares

Optomed PlcStock Exchange Release7 August 2023 at 15.30, Helsinki Change in Optomed's holding of treasury shares Optomed has conveyed 15,093 treasury shares to the members of the Board of Directors as a part of the Board members' annual remuneration in accordance with the decision of the Annual General Meeting 2023. The amount of shares is based on the monthly remuneration decided by the Annual General Meeting and Optomed's value weighted average share price between 28 July and 3 August 2022. A total of 1,000 of shares have been subscribed for under the Company's stock option plan 2018C and Optomed has used treasury shares for the share subscriptions. The subscribed shares have been delivered to the subscribers on 7 August 2023. The total amount of treasury shares is now 353,973. Optomed Plc Further enquiries Sakari Knuutti, CFO, Optomed Plc, sakari.knuutti@optomed.com Optomed in Brief Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.